The US Food and Drug Administration has given the go-ahead to remdesivire making it the first drug specifically approved to treat Covid-19.
The F.D.A. said the drug had been approved for adults and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) who require hospitalization for Covid-19, the disease caused by the coronavirus, which has killed more than 220,000 people in the United States.
The formal approval by the F.D.A. indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of clinical data and manufacturing quality since it was given emergency authorization in May.
Trials of the antiviral drug have shown it may not have significant benefits for some coronavirus patients, but it’s what we have now.
Elsewhere on the medical front, a new report from the Center for Infectious Disease Research and Policy reveals the pandemic is causing “unacceptable” shortages of US drug supplies.
The report says shortages have limited 29 of 40 drugs critical for treating Covid-19 patients, including hydroxychloroquine and fentanyl, as well as 67 out of 156 other critical acute drugs.